Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Neoplasms 4Mycoses 3Leukemia 3Infections 3Recurrence 2Neutropenia 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Triple Negative Breast Neoplasms 1Torulopsis 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Stem Cell Transplant Complications 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumours 1Sezary Syndrome 1Seminoma 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Cyclophosphamide 31fludarabine phosphate 25Peripheral Blood Stem Cell Transplantation 24Busulfan 22Antilymphocyte Serum 19Filgrastim 17Cyclosporine 16Tacrolimus 15Radiotherapy 15Methotrexate 14Mycophenolic Acid 12Etoposide 12Cytarabine 11Whole-Body Irradiation 10Methylprednisolone 10Melphalan 10Cyclosporins 6Cord Blood Stem Cell Transplantation 6sargramostim 5Psychiatric Rehabilitation 5Flow Cytometry 5ruxolitinib 4Thiotepa 4Thalidomide 4Early Intervention, Educational 4Azacitidine 4Alemtuzumab 4Tretinoin 3Sirolimus 3Polymerase Chain Reaction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Myelodysplastic-Myeloproliferative Diseases × Fluconazole × Clear all
NCT00075803 2023-01-04

BMT CTN 0101

Medical College of Wisconsin

Phase 3 Completed
600 enrolled 22 charts
LymphoidMyeloidOther hematologic neoplasm

Infections, Leukemia, Lymphoma, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡